{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01236",
      "entity_text" : "PRL",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0923" ],
      "CellType" : [ "cl:CL:0000235" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Previously, a small number of open-label clinical trials using bromocriptine, which indirectly decreases PRL levels, were performed in RA patients and showed clinical benefit, although others found the opposite effect.",
  "reading_complete" : "2020-08-04T10:53:10Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T10:52:14Z",
  "trigger" : "levels",
  "evidence" : [ "PRL levels" ],
  "pmc_id" : "5481306",
  "score" : 0
}